LORRAIN DANIEL S.

PrivateCIK: 1861550
Location

SAN DIEGO, CA

LORRAIN DANIEL S. (Chief Scientific Officer) sold 4.9% of their position (8.12K shares) of CONTINEUM THERAPEUTICS, INC. on the open market

Open‑market sale worth $130.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 2 sales
InsiderLORRAIN DANIEL S.CIK 1861550
Officer· Chief Scientific Officer
Since Mar 2026
-8.12K
Net shares
Net seller
$130.2K
Total sold
2
Open market trades
0B · 2S
6
Total transactions
8.12K acquired · 16.25K disposed
Non-Derivative Transactions4

Class A Common Stock

Direct
M · Option Exercise

Shares

+4.30K

Price / share

$1.01

Trade value

$4.34K

% of position

2.8%
2/24/2026
156.05K160.35K

Class A Common Stock

Direct
S · Sale

Shares

4.30K

Price / share

$16.03

Trade value

$68.94K

% of position

2.7%
2/24/2026
160.35K156.05K

Class A Common Stock

Direct
M · Option Exercise

Shares

+3.82K

Price / share

$1.01

Trade value

$3.86K

% of position

2.5%
2/25/2026
156.05K159.88K

Class A Common Stock

Direct
S · Sale

Shares

3.82K

Price / share

$16.01

Trade value

$61.23K

% of position

2.4%
2/25/2026
159.88K156.05K
Total

Net shares

+0.00

Net value

-$121.96K

Derivative Transactions2

Stock Option (right to buy)

Direct
M · Option Exercise
Converts to

Class A Common Stock

4.30K shares

Shares

4.30K

Strike price

1.01

Held after

71.13K

Exercisable

2/24/2026

Stock Option (right to buy)

Direct
M · Option Exercise
Converts to

Class A Common Stock

3.82K shares

Shares

3.82K

Strike price

1.01

Held after

67.31K

Exercisable

2/25/2026
Non-Derivative Holdings (Post-Transaction)1

Class A Common Stock

Indirect
Shares owned6.84K
Total
6.84K indirect6.84K
Derivative Holdings (Post-Transaction)0
No derivative holdings reported
LORRAIN DANIEL S. — Insider Transaction (Form 4) Filed Feb 26, 2026 | Finecho